CA3288355A1 - Conjugués anticorps-médicament - Google Patents

Conjugués anticorps-médicament

Info

Publication number
CA3288355A1
CA3288355A1 CA3288355A CA3288355A CA3288355A1 CA 3288355 A1 CA3288355 A1 CA 3288355A1 CA 3288355 A CA3288355 A CA 3288355A CA 3288355 A CA3288355 A CA 3288355A CA 3288355 A1 CA3288355 A1 CA 3288355A1
Authority
CA
Canada
Prior art keywords
drug conjugates
antibody drug
antibody
conjugates
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3288355A
Other languages
English (en)
Inventor
Chuan Wang
Xinling Zhang
Ning Zhang
Yongwang Li
Xuelian Liu
Mengyao Zhu
Yongli Yang
Jingyu SUN
Zhijin Ye
Fei Ma
Jingjing Ji
Fu Li
Archie Ngai-Chiu Tse
Jianxin Yang
Original Assignee
Tuo Shi Pharmaceuticals Shanghai Co Ltd
CStone Pharmaceuticals Suzhou Co Ltd
Cstone Pharmaceuticals Vistra Cayman Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tuo Shi Pharmaceuticals Shanghai Co Ltd, CStone Pharmaceuticals Suzhou Co Ltd, Cstone Pharmaceuticals Vistra Cayman Ltd filed Critical Tuo Shi Pharmaceuticals Shanghai Co Ltd
Publication of CA3288355A1 publication Critical patent/CA3288355A1/fr
Pending legal-status Critical Current

Links

CA3288355A 2023-04-07 2024-04-07 Conjugués anticorps-médicament Pending CA3288355A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNPCT/CN2023/086988 2023-04-07
CNPCT/CN2024/084464 2024-03-28

Publications (1)

Publication Number Publication Date
CA3288355A1 true CA3288355A1 (fr) 2024-10-10

Family

ID=

Similar Documents

Publication Publication Date Title
AU2021374958A9 (en) Antibody drug conjugates
IL313805A (en) Drug antibody conjugates
EP4171655A4 (fr) Conjugués anticorps-médicament comprenant des anticorps anti-b7-h3
EP4217398A4 (fr) Conjugués anticorps-médicament anti-c-met
IL317447A (en) Antibody-drug conjugates
AU2021260792B2 (en) Drug antibody conjugates
IL321698A (en) Antibody B7H3 Drug
EP4130036A4 (fr) Conjugué anticorps-médicament
CA3268311A1 (fr) Conjugués de néo-dégradateurs
CA3278026A1 (fr) Conjugués anticorps-médicament
AU2022298653A9 (en) Anti-egfrviii antibody drug conjugates and uses thereof
CA3303200A1 (fr) Conjugués anticorps-médicament anti-doppel
HK40124190A (en) Antibody drug conjugates
HK40117329A (en) Antibody drug conjugates
HK40116669A (en) Antibody drug conjugates
HK40084712A (en) Drug antibody conjugates
HK40124216A (en) Anti-cd19 antibody drug conjugates
CA3278402A1 (fr) Conjugués anticorps-médicament b7h3
IL326788A (en) Anti-Duple antibody conjugates
HK40100658A (zh) 抗c-met抗体药物结合物
CA3288936A1 (fr) Conjugués ligand-médicament polaire
HK40128656A (zh) 抗-cd45-ign抗体药物偶联物及其用途
HK40129345A (en) Ecteinascidin derivative antibody drug conjugates
CA3273282A1 (fr) Conjugués anticorps-médicament dérivés d'ecteinascidine
HK40102683A (zh) 新降解剂-抗-cd33抗体缀合物